---

$1.02

-0.0950 ( -8.56% ) 3.4M

Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2024-06-06	Sale	-600000.00	Lee Timothy Edward
2024-05-31	Sale	-112381.00	MCGUIRE TERRANCE
2024-05-23	Sale	-50000.00	Berry Tamsin
2024-05-23	Sale	-100000.00	MCLAUGHLIN KEVIN F
2024-05-23	Sale	-41369.00	Cotter Sara
2024-05-23	Sale	-50000.00	MCGUIRE TERRANCE